10x Genomics TXG
NASDAQ TXG
$63.20 +1.55 (+2.52%)
As of: Sep 3, 2026 · 3:59 PM EDT

10x Genomics (TXG) Cash from Investing Activities Growth (1y) (2019 - 2026)

Analysis

10x Genomics (TXG) Cash from Investing Activities Growth (1y) (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Veeva Systems 46.14 Bn 38.90 Bn 695.95 Mn 83.68%
2 BrightSpring Health Services 12.64 Bn 12.07 Bn 492.75 Mn -21.32%
3 Tempus AI 11.63 Bn 10.82 Bn 274.25 Mn -16.62%
4 Healthequity 8.23 Bn 7.98 Bn 257.95 Mn -131.80%
5 10x Genomics 8.23 Bn 7.68 Bn 112.50 Mn -723.75%
6 Hinge Health 7.20 Bn 6.81 Bn 183.95 Mn 611.71%
7 MiniMed 6.10 Bn 5.81 Bn 480.00 Mn 1.75%
8 Waystar Holding 4.99 Bn 4.80 Bn 221.99 Mn -118.44%
9 Doximity 4.92 Bn 4.23 Bn 132.93 Mn 4,117.62%
10 Heartflow 4.30 Bn 3.92 Bn 53.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -723.75%
Mar 31, 2026 30.74%
Dec 31, 2025 96.50%
Sep 30, 2025 -143.26%
Jun 30, 2025 -107.86%
Mar 31, 2025 -117.80%
Dec 31, 2024 -493.89%
Sep 30, 2024 -173.84%
Jun 30, 2024 367.75%
Mar 31, 2024 -91.14%
Dec 31, 2023 139.49%
Sep 30, 2023 115.02%
Jun 30, 2023 83.79%
Mar 31, 2023 146.57%
Dec 31, 2022 -20.11%
Sep 30, 2022 -61.32%
Jun 30, 2022 -88.96%
Mar 31, 2022 -481.19%
Dec 31, 2021 -24.04%
Sep 30, 2021 -1,444.05%